Jump to main content
Jump to site search

Issue 22, 2014
Previous Article Next Article

Macromolecular (pro)drugs in antiviral research

Author affiliations

Abstract

Macromolecular (pro)drugs are a sub-discipline of medicinal and polymer chemistries aiming to optimize the delivery of drugs to their site of action. In recent decades, this field of science has undergone a tremendous development, with the soundest achievements registered in the delivery of anticancer drugs. Surprisingly, the development of these tools for applications in antiviral treatment lags significantly behind – despite the fact that the first in vivo successes of polymers in fighting viruses were reported half a century ago. Furthermore, the unique scope and utility of polymers in antiviral research is that macromolecules themselves exhibit highly potent activity against diverse viruses. Herein, in an attempt to revive the research interest in this field, we aim to provide an overview of successes (and failures) of polymers as antiviral agents and macromolecular prodrugs. Specifically, we discuss inhibition of the entry of the virus into mammalian cells by polymers, give an overview of the synthetic schemes applied for the conjugation of drugs to carrier polymers, and also present guidance with regard to potential reporter systems which can be used for the characterization of novel drug delivery systems in virus-free cell cultures.

Graphical abstract: Macromolecular (pro)drugs in antiviral research

Back to tab navigation

Publication details

The article was received on 05 May 2014, accepted on 17 Jun 2014 and first published on 30 Jun 2014


Article type: Review Article
DOI: 10.1039/C4PY00624K
Citation: Polym. Chem., 2014,5, 6407-6425
  •   Request permissions

    Macromolecular (pro)drugs in antiviral research

    A. A. A. Smith, M. B. L. Kryger, B. M. Wohl, P. Ruiz-Sanchis, K. Zuwala, M. Tolstrup and A. N. Zelikin, Polym. Chem., 2014, 5, 6407
    DOI: 10.1039/C4PY00624K

Search articles by author

Spotlight

Advertisements